Panion & Bf Biotech Inc.

Taiwan Stock Exchange 1760.TW

Panion & Bf Biotech Inc. Current Liabilities for the year ending December 31, 2023: USD 34.23 M

Panion & Bf Biotech Inc. Current Liabilities is USD 34.23 M for the year ending December 31, 2023, a 13.86% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Panion & Bf Biotech Inc. Current Liabilities for the year ending December 31, 2022 was USD 30.06 M, a 12.54% change year over year.
Panion & Bf Biotech Inc. Current Liabilities for the year ending December 31, 2021 was USD 26.71 M, a -20.58% change year over year.
Panion & Bf Biotech Inc. Current Liabilities for the year ending December 31, 2020 was USD 33.63 M, a 156.54% change year over year.
Panion & Bf Biotech Inc. Current Liabilities for the year ending December 31, 2019 was USD 13.11 M, a -5.05% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Taiwan Stock Exchange: 1760.TW

Panion & Bf Biotech Inc.

CEO	Mr. Tsung-Ming Chiang
IPO Date	Dec. 20, 2007
Location	Taiwan
Headquarters	Building F
Employees	321
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals

Description

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years